1.	Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation Phase: Phase III, Phase II Type: Supportive care Status: Completed Age: Over 12 Sponsor: NCI, Other Protocol IDs: 1001.00, FHCRC-1001.00, NCI-G01-2008, CDR0000068886, NCT00024037
2.	Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase: Phase III, Phase II Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000592644, RTOG-0537, NCT00656513
3.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Sucralfate to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 05/94) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-929251, NCI-P94-0054
4.	Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-1Z93, NCI-P94-0059
5.	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97) Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-959251, NCI-P95-0069
6.	Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065912, RTOG-9709, NCI-P97-0121, NCT00003139
7.	Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000066260, RTOG-9801, NCT00003313
8.	Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000066687, NCCTG-969257, NCI-P98-0136, NCT00003610
9.	Phase III Randomized Study of Nystatin in Patients Receiving High Dose Interleukin-2 (Summary Last Modified 07/2000) Phase: Phase III Type: Supportive care Status: Completed Age: 16 to 65 Sponsor: NCI Protocol IDs: NCI-99-C-0097
10.	Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000068406, RTOG-9901, NCI-P00-0177, NCT00008398
11.	Phase III Randomized Study of Recombinant Human Keratinocyte Growth Factor in Reducing Therapy-Induced Oral Mucositis in Patients With Hematologic Malignancies Undergoing Total Body Irradiation and High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0012064, AMGEN-KGF-20000162, FHCRC-1612.00, MSKCC-01065, NCI-G01-1961
12.	Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068810, UCLA-0008049, IBP-PG-015, NCI-G01-2001, NCT00022373
13.	Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069337, NCCTG-N01C4, NCI-P02-0224, N01C4, NCT00036881
14.	Phase III Study of the Role of Cricopharyngeal Myotomy in the Treatment of Dysphagia Following Major Surgery for Head and Neck Carcinomas (Summary Last Modified 08/91) Phase: Phase III Type: Supportive care Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: RTOG-8530, SWOG-8895
15.	Phase III Placebo-Controlled Study of the Inhibition of Radiotherapy-Induced Stomatitis with Chlorhexidine Mouthwash or Oral Antibiotics (Tobramycin/Polymixin E/Amphotericin B) in Patients Receiving Radiotherapy to the Oral Cavity Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-909253, MAYO-909253, NCI-P91-0013
16.	Phase III Study of Chamomile Mouthwash for Stomatitis Prophylaxis in Patients Receiving 5-FU-Based Chemotherapy (Summary Last Modified 02/92) Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-909256, MAYO-909256, NCI-P92-0001
17.	Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000491088, RTOG-0435, NCT00360971
18.	Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: 03-131, R21CA098792, P30CA008748, MSKCC-03131A, NCT00090337
19.	Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000068231, RTOG-0022, RTOG-H-0022, RTOG-DEV-1065, NCT00006360
20.	Phase II Study of Radioprotection of Oral and Pharyngeal Mucosa by the Prostaglandin E1 Analog Misoprostol (Summary Last Modified 07/1999) Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9607, NCI-P97-0120, RTOG-96-07
21.	Phase II Randomized Study of Recombinant Human Keratinocyte Growth Factor in Patients with Hematologic Malignancies Undergoing Total Body Irradiation and High Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Support. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 to 65 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-99029, AMGEN-KGF-980231-04, NCI-G99-1574, NCT00004061
22.	Phase II Randomized Study of Recombinant Human Keratinocyte Growth Factor for Oral Mucositis in Patients With Hematologic Malignancies Undergoing Radiotherapy and High Dose Chemotherapy Prior to Autologous Peripheral Blood Stem Cell Transplantation. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 12 to 65 Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-9812041, AMGEN-KGF-980231-03, NCI-G99-1609, NCT00004132
23.	Phase II Trial of G-CSF as an Oral Mucosal Protectant in Patients with Malignant Disease Receiving 5-FU plus Low-Dose CF Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UPCC-5990, NCI-T90-0163D, T90-0163
24.	Phase II Randomized Study of RK-0202 to Prevent Radiotherapy-Induced Oral Mucositis in Patients With Tumors of the Oral Cavity, Oropharynx, Nasopharynx, Salivary Glands, or Supraglottic Region Phase: Phase II Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0205011, NCI-G02-2111, RK-0202:02, NCT00046956
25.	Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 to 80 Sponsor: NCI, Other Protocol IDs: CDR0000287213, RTOG-0244, NCT00068237